This protocol applies to patients with coarctation of the aorta who have concurrent hypertension — a recognised and clinically significant comorbidity in this population requiring structured management.
Hypertension is a common finding in patients with coarctation of the aorta. The relationship between the structural defect and elevated blood pressure makes it important to address both. A significant non-invasive gradient between the upper and lower limbs may also be relevant to clinical decision-making in this setting.
Hypertension in patients with coarctation of the aorta is managed according to established international hypertension guidelines. The complete structured regimen — including specific options, sequencing, and monitoring targets — is available in the full protocol.
DOI: 10.1093/eurheartj/ehae179
It is recommended to treat hypertension in patients with coarctation according to ESC hypertension guidelines.
Coarctation or re-coarctation repair (either surgical or endovascular) is indicated in patients with hypertension with an increased non-invasive gradient between the upper and lower limbs (decreased ABI) confirmed with invasive measurement (peak-to-peak >20 mmHg), with a preference for stenting when technically feasible.
View source ↗